Sun Pharma Acquires Checkpoint Therapeutics to Expand Oncology and Immunotherapy Portfolio 2 years ago AnaIn Funding RoundsPartnershipsPharma Industry UpdatesTop Stories
AstraZeneca’s Billion-Dollar Acquisition and Strategic Deals Highlight March Biopharma M&A Boom 2 years ago AnaIn Funding RoundsPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Eli Lilly’s EBGLYSS Shows Sustained Skin Clearance at Three Years in Moderate-to-Severe Atopic Dermatitis 2 years ago AnaIn Biopharma HighlightsClinical TrialsInnovationTop Stories
Breakthrough Collaborations in AI-Driven Drug Discovery Accelerate Biopharma Innovation 2 years ago AnaIn AI & DataInnovationPartnershipsPharma Industry Updates
Sustained Growth in Cell and Gene Therapy Manufacturing Sparks New Opportunities in North America 2 years ago AnaIn Biopharma ManufacturingFunding RoundsInnovationPharma Industry UpdatesTop Stories
Pharma Industry Updates: Europe’s Fast-Track Approvals Fuel Growth in Rare Disease Therapeutics 2 years ago AnaIn FDA ApprovalsFunding RoundsPharma Industry UpdatesResearch UpdatesVenture Capital
Industry Conferences Drive Biopharma Collaboration and Innovation Across Asia-Pacific 2 years ago AnaIn Industry ConferencesInnovationPartnershipsPharma Industry UpdatesTop Stories
Venture Capital Surge Fuels Australian Biotech Startups in Oncology and Rare Diseases 2 years ago AnaIn Funding RoundsPartnershipsResearch UpdatesStartupsTop StoriesVenture Capital
Breakthrough in Alzheimer’s Prevention: New Trial Shows Promise for First-in-Class Early Intervention Therapy 2 years ago AnaIn Clinical TrialsInnovationPartnershipsResearch UpdatesTop Stories
Continuous Glucose Monitoring Developer Secures Injection of Capital to Fuel Diagnostic Innovation 2 years ago AnaIn BreakthroughsInnovationPharma Industry Updates
Venture Capital Flows Back Into Biotech With Renewed Strength 2 years ago AnaIn Top StoriesVenture Capital
Afrigen and Tourmaline Secure Major Funding to Advance Critical Clinical Research and Therapeutics 2 years ago AnaIn Biopharma HighlightsResearch Updates
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships 2 years ago AnaIn DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing 2 years ago AnaIn Funding RoundsInvestmentsPeopleVenture Capital
EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders 2 years ago AnaIn Breaking NewsLeaders
